“Preservative-free” can sound like the obvious answer after a rash. But preservatives keep many water-containing products stable while they travel, sit on a shelf, and meet wet fingertips. The more useful question is narrower: if you have a confirmed contact allergy, which preservative was it, and where might that exact substance show up?

Recent research on the isothiazolinones—methylisothiazolinone (MI), methylchloroisothiazolinone/MI (MCI/MI), and benzisothiazolinone (BIT)—shows why specificity matters. These substances are related, but a family name alone does not establish that every member will trigger the same person. A clinician who interprets patch testing can turn a positive result into an exposure plan; a broad ingredient blacklist cannot do that job.

What the big review measured

A 2026 systematic review and meta-analysis combined 115 studies covering 1,514,781 dermatitis patients from 2000 through 2025. Its pooled patch-test prevalence estimates were 5.48% for MI, 4.58% for MCI/MI, and 2.09% for BIT. Read the review.

Those figures are important, but they are easy to overread. They describe selected patients evaluated for dermatitis across many years, countries, testing approaches, and referral settings. They are not a 2026 population prevalence estimate and do not say that a randomly chosen shopper has the same chance of allergy.

The review also records an important change over time: MI sensitization declined in European data after restrictions, while BIT use in surveillance data drew growing attention, including in household and industrial-use contexts. That is a public-health observation, not proof that BIT is rising everywhere or that one product category explains every reaction.

The name on the test matters

MI, MCI/MI, and BIT are not interchangeable labels. Ask for your exact positive allergen and the names that should appear on relevant ingredient lists or product information.

A twenty-year local study adds useful restraint

A follow-up study from Gran Canaria, Spain, covering 2003 to 2025 found declining sensitization to MI and MCI/MI and flat, sustained BIT sensitization in that clinic population. Read the study. It is a valuable long view, but it is still one location and one clinical population—not evidence of a global BIT “epidemic.”

That measured language matters. Trends can differ by local product availability, occupational exposure, patch-test series, and the people referred for testing. The best interpretation is that surveillance helps identify questions worth asking, while an individual diagnosis rests on a clinician’s assessment of symptoms, exposure, and patch-test relevance.

Look beyond the bathroom shelf

When people hear “preservative,” they often picture lotion or shampoo. For isothiazolinones, the exposure inventory may be wider. Depending on the substance and product, it can include personal-care products, household cleaners, laundry-related products, paints, or workplace materials. A confirmed allergy may call for reviewing the full range of products you touch, including products used at work or in cleaning—not only cosmetics.

That is also why product category shortcuts can mislead. “Natural,” “chemical-free,” or “for sensitive skin” does not verify that a product is compatible with a particular patch-test result. Conversely, an ingredient name that sounds unfamiliar is not a diagnosis. Use the ingredient list, safety documentation when relevant, and clinical guidance for the allergen you have actually been shown to react to.

Formaldehyde and its releasers deserve the same precision

Isothiazolinones are not the whole preservative story. A separate 2026 meta-analysis reviewed 158 studies involving 1,347,638 dermatitis patients to estimate contact allergy to formaldehyde and five common formaldehyde releasers. The authors found substantial geographic variation and very high heterogeneity, reasons to avoid treating one pooled figure as a universal answer. Read the formaldehyde review.

In practice, a result to formaldehyde, a formaldehyde releaser, MI, MCI/MI, or BIT should prompt a distinct conversation. It does not establish that all preservatives are harmful, that all isothiazolinones are proven cross-reactive for you, or that any “preservative-free” product is automatically appropriate.

Use research as a map, not a shopping rule

If you have a documented positive patch test, keep a copy of the report and ask your dermatologist or allergist how to read it in the context of your daily exposures. Review the full ingredient list for the products you use repeatedly, and mention cleaners, hobbies, and workplace materials when discussing a persistent rash. If a new or worsening reaction concerns you, seek clinical advice rather than trying to confirm an allergy by testing products on yourself.

Research can sharpen the questions. The answer still comes from the exact allergen, the real-world exposure, and qualified clinical interpretation.

Sources